WEST PHARMACEUTICAL SERVICES, INC. Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31)
WEST PHARMACEUTICAL SERVICES, INC. (WST) reported Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) of $0 for the 3-month period ending 2012-03-31, per its 10-Q filed 2012-05-04.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeDerivativesQualifyingAsHedgesNetOfTaxPeriodIncreaseDecrease · last filed 2012-05-04
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $0.00.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-12-31 was $0.00, a 100.00% decline year-over-year.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-09-30 was -$400.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for the quarter ending 2011-06-30 was -$500.00K.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2011 was -$1.70M.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2010 was -$300.00K, a 115.00% decline from fiscal 2009.
- WEST PHARMACEUTICAL SERVICES, INC. other comprehensive income (loss), derivatives qualifying as hedges, net of tax (deprecated 2012-01-31) for fiscal 2009 was $2.00M.
| Period end | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 3 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 6 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 9 month | Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax (Deprecated 2012-01-31) 12 month |
|---|---|---|---|---|
| 2012-03-31 | $0.00 10-Q · filed 2012-05-04 | $0.00 derived: sum of 2 quarters · filed 2012-05-04 | -$400.00K derived: sum of 3 quarters · filed 2012-05-04 | -$900.00K derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | -$400.00K derived: sum of 2 quarters · filed 2012-03-01 | -$900.00K derived: sum of 3 quarters · filed 2012-03-01 | -$1.70M 10-K/A · filed 2012-03-01 |
| 2011-09-30 | -$400.00K 10-Q · filed 2011-11-07 | -$900.00K derived: sum of 2 quarters · filed 2011-11-07 | -$1.70M 10-Q · filed 2011-11-07 | -$1.00M derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-06-30 | -$500.00K 10-Q/A · filed 2011-08-08 | -$1.30M 10-Q/A · filed 2011-08-08 | -$600.00K derived: sum of 3 quarters · filed 2012-05-04 | -$900.00K derived: sum of 4 quarters · filed 2012-05-04 |
| 2011-03-31 | -$800.00K 10-Q · filed 2012-05-04 | -$100.00K derived: sum of 2 quarters · filed 2012-05-04 | -$400.00K derived: sum of 3 quarters · filed 2012-05-04 | -$800.00K derived: sum of 4 quarters · filed 2012-05-04 |
| 2010-12-31 | $700.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-01 | $400.00K derived: sum of 2 quarters · filed 2012-03-01 | $0.00 derived: sum of 3 quarters · filed 2012-03-01 | -$300.00K 10-K/A · filed 2012-03-01 |
| 2010-09-30 | -$300.00K 10-Q · filed 2011-11-07 | -$700.00K derived: sum of 2 quarters · filed 2011-11-07 | -$1.00M 10-Q · filed 2011-11-07 | |
| 2010-06-30 | -$400.00K 10-Q/A · filed 2011-08-08 | -$700.00K 10-Q/A · filed 2011-08-08 | ||
| 2009-12-31 | $2.00M 10-K/A · filed 2012-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |